Correlation among Clinicopathological Parameters of Myocardial Damage in Rats Treated with Isoproterenol

DOI Web Site Web Site PubMed 3 Citations 24 References
  • KURATA Masaaki
    Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.
  • IIDAKA Takeshi
    Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.
  • SASAYAMA Yukiko
    Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.
  • FUKUSHIMA Tamio
    Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.
  • SAKIMURA Masanori
    Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.
  • SHIRAI Norimitsu
    Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.

Search this article

Abstract

The correlation among clinicopathological parameters of myocardial damage was investigated in rats administered a single subcutaneous dose of isoproterenol at 0 (saline), 0.04, 0.4 and 4 mg/kg. Total lactate dehydrogenase (LDH), creatine kinase (CK), and their isoenzymes (LDH-1, LDH-2 and CK-MB), as well as troponin I and tropinin T, were measured 4 h after the administration of the drug. Troponin I was determined by a chemiluminescence method using Bayer Centaur and DPC Immulyze, as well as by ELISA. Troponin T was assayed semi-quantitatively using Trop T Sensitive. A high correlation was found among LDH isoenzymes, troponin I (Centaur) and troponin T. The present result provides a baseline for interpreting changes in the different parameters of myocardial damage assayed by different methods in toxicity studies.<br>

Journal

  • Experimental Animals

    Experimental Animals 56 (1), 57-62, 2007

    Japanese Association for Laboratory Animal Science

Citations (3)*help

See more

References(24)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top